Filip Goossens

1.8k total citations
37 papers, 1.5k citations indexed

About

Filip Goossens is a scholar working on Oncology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Filip Goossens has authored 37 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 19 papers in Cellular and Molecular Neuroscience and 12 papers in Molecular Biology. Recurrent topics in Filip Goossens's work include Peptidase Inhibition and Analysis (25 papers), Neuropeptides and Animal Physiology (19 papers) and Signaling Pathways in Disease (8 papers). Filip Goossens is often cited by papers focused on Peptidase Inhibition and Analysis (25 papers), Neuropeptides and Animal Physiology (19 papers) and Signaling Pathways in Disease (8 papers). Filip Goossens collaborates with scholars based in Belgium, United States and Italy. Filip Goossens's co-authors include Simon Scharpé, Ingrid De Meester, Dirk Hendriks, Greet Vanhoof, Simon Scharpé, Michaël Maes, K. Schatteman, Herbert Y. Meltzer, Koen Augustyns and Roger Desnyder and has published in prestigious journals such as Biological Psychiatry, The FASEB Journal and European Journal of Biochemistry.

In The Last Decade

Filip Goossens

35 papers receiving 1.4k citations

Peers

Countries citing papers authored by Filip Goossens

Since Specialization

Citations

This map shows the geographic impact of Filip Goossens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Filip Goossens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Filip Goossens more than expected).

Fields of papers citing papers by Filip Goossens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Filip Goossens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Filip Goossens. The network helps show where Filip Goossens may publish in the future.

Co-authorship network of co-authors of Filip Goossens

This figure shows the co-authorship network connecting the top 25 collaborators of Filip Goossens. A scholar is included among the top collaborators of Filip Goossens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Filip Goossens. Filip Goossens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	From discovery to innovation in animal health: Maturing emerging technologies for industrial development 2024 ·Biologicals ·Johannes Charlier, (unknown), (unknown), Emmanuel Hanon, Matthias D. Hofer, Filip Goossens, Sven Arnouts	0
2	Online on-the-spot searching increases use of evidence during consultations in family practice 2007 ·Patient Education and Counseling ·(unknown), Bert Aertgeerts, Karin Hannes, (unknown), (unknown), Filip Goossens, (unknown)	20
3	Properties of recombinant human plasma procarboxypeptidase U produced in mammalian and insect cells 2004 ·Clinica Chimica Acta ·Mats Strömqvist, Lennart Hansson, (unknown), (unknown), Michael Edlund, (unknown), Filip Goossens, Simon Scharpé, Dirk Hendriks	8
4	Natural Substrates of Dipeptidyl Peptidase IV 2002 ·Advances in experimental medicine and biology ·Ingrid De Meester, Christine Durinx, Gunther Bal, Paul Proost, Sofie Struyf, Filip Goossens, Koen Augustyns, Simon Scharpé	68
5	Fast Homogeneous Assay for Plasma Procarboxypeptidase U 2001 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·K. Schatteman, Filip Goossens, Judith Leurs, Yasushi Kasahara, (unknown), Dirk Hendriks	13
6	Effects of pregnancy and delivery on serum prolyl endopeptidase (PEP) activity: alterations in serum PEP are related to increased anxiety in the early puerperium and to postpartum depression 2000 ·Journal of Affective Disorders ·Michaël Maes, (unknown), Aihua Lin, Filip Goossens, Willem Ombelet, (unknown), Eugène Bosmans, Carlo Altamura, John Cox, Raf De Jongh, Simon Scharpé	11
7	Proteolytic activation of purified human procarboxypeptidase U 2000 ·Clinica Chimica Acta ·K. Schatteman, Filip Goossens, Simon Scharpé, Dirk Hendriks	45
8	Higher serum prolyl endopeptidase activity in patients with post-traumatic stress disorder 1999 ·Journal of Affective Disorders ·Michaël Maes, Ai-Hua Lin, Stefania Bonaccorso, Filip Goossens, Ann Van Gastel, Rosaria Pioli, Laure Delmeire, Simon Scharpé	42
9	Lower Activity of Serum Peptidases in Abstinent Alcohol-Dependent Patients 1999 ·Alcohol ·Michaël Maes, Aihua Lin, Stefania Bonaccorso, Eric Vandoolaeghe, Cai Song, Filip Goossens, Ingrid De Meester, (unknown), Hugo Neels, Simon Scharpé, (unknown)	13
10	ChemInform Abstract: The Unique Properties of Dipeptidyl‐Peptidase IV (DPP IV / CD26) and the Therapeutic Potential of DPP IV Inhibitors 1999 ·ChemInform ·Koen Augustyns, (unknown), (unknown), (unknown), (unknown), (unknown), Anne‐Marie Lambeir, Christine Durinx, Filip Goossens, Achiel Haemers	1
11	Lower serum activity of prolyl endopeptidase in fibromyalgia is related to severity of depressive symptoms and pressure hyperalgesia 1998 ·Psychological Medicine ·Michaël Maes, (unknown), Fran Van Hunsel, Ai Lin, S. Bonaccorso, Filip Goossens, Ingrid De Meester, Luc S. De Clerck, Massimo Biondi, Simon Scharpé, (unknown)	26
12	Isolation and sequence analysis of a human cDNA clone (XPNPEPL) homologous to X-prolyl aminopeptidase (aminopeptidase P) 1997 ·Cytogenetic and Genome Research ·Greet Vanhoof, Filip Goossens, María A. Juliano, L. Juliano, Dirk Hendriks, K. Schatteman, (unknown), Simon Scharpé	8
13	145 Procarboxypeptidase u is expressed in human liver 1997 ·Fibrinolysis & proteolysis ·Greet Vanhoof, K. Schatteman, Filip Goossens, (unknown), Dirk Hendriks	7
14	The Gene for Human Carboxypeptidase U (CPU)— A Proposed Novel Regulator of Plasminogen Activation— Maps to 13q14.11 1996 ·Genomics ·(unknown), J. Wauters, K. Schatteman, Dirk Hendriks, Filip Goossens, Paul Bossuyt, Simon Scharpé	35
15	The Purification, Characterization and Analysis of Primary and Secondary‐Structure of Prolyl Oligopeptidase from Human Lymphocytes 1995 ·European Journal of Biochemistry ·Filip Goossens, Ingrid De Meester, Greet Vanhoof, Dirk Hendriks, Gert Vriend, Simon Scharpé	42
16	Synthesis of peptidyl acetals as inhibitors of prolyl endopeptidase 1995 ·Bioorganic & Medicinal Chemistry Letters ·Koen Augustyns, (unknown), (unknown), Padinchare Rajan, Filip Goossens, Dirk Hendriks, Simon Scharpé, Achiel Haemers	11
17	Lower serum prolyl endopeptidase enzyme activity in major depression: Further evidence that peptidases play a role in the pathophysiology of depression 1994 ·Biological Psychiatry ·Michaël Maes, Filip Goossens, Simon Scharpé, Herbert Y. Meltzer, Peter D'Hondt, Paul Cosyns	100
18	Cloning and sequence analysis of the gene encoding human lymphocyte prolyl endopeptidase 1994 ·Gene ·Greet Vanhoof, Filip Goossens, Lydia Hendriks, Ingrid De Meester, Dirk Hendriks, Gert Vriend, Christine Van Broeckhoven, Simon Scharpé	40
19	Kininase activity in human platelets: Cleavage of the Arg1-Pro2 bond of bradykinin by aminopeptidase P 1992 ·Biochemical Pharmacology ·Greet Vanhoof, Ingrid De Meester, Filip Goossens, Dirk Hendriks, Simon Scharpé, Arieh Yaron	29
20	A sensitive method for the assay of serum prolyl endopeptidase. 1992 ·PubMed ·Filip Goossens, Ingrid De Meester, Greet Vanhoof, Simon Scharpé	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact